MLLT3 and breast carcinoma: Levels of AF9 protein in tissues were scored into four grades (Figure 7G), and the patients with multiple organ metastasis expressed low AF9 levels (Figure 7H), suggesting that reduced AF9 expression marks malignant progression in breast cancer patients.